Netherbeck

About Netherbeck

This author has not yet filled in any details.
So far Netherbeck has created 27 blog entries.

St. Jude Medical Announces European Launch of Smaller Quadripolar Pacing System

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the European launch of the Unify Quadra(TM) cardiac resynchronization therapy defibrillator (CRT-D). The Unify Quadra CRT-D works with the company's Quartet(TM) left ventricular pacing lead. The combined system offers physicians the ability to effectively and efficiently manage the changing pacing needs of patients [...]

September 23rd, 2011|News|

Cellnovo receives CE mark approval for world’s first mobile diabetes management system

LONDON, UK – February 4, 2011 – Cellnovo, developer of the first mobile diabetes management system, announced today that it raised ₤30 million ($48.4 million) in a Series B financing round led by Edmond de Rothschild Investment Partners (EdRIP), with Forbion Capital Partners; Auriga Partners; NBGI Ventures and Credit Agricole Private Equity joining Series A [...]

September 23rd, 2011|News|

Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave

SAN DIEGO, Sept. 20, 2011 /PRNewswire via COMTEX/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced today that following a recent meeting with senior officials in FDA's Office of New Drugs (OND), the Company received written correspondence detailing OND's design requirements for a cardiovascular outcomes trial (CVOT) for Contrave® that would address the Complete Response Letter [...]

September 23rd, 2011|News|

Clinical Trial Design & Optimisation For Medical Technology

An improved clinical trial design offers a wide range of opportunity for better science, better ethics and better R&D investment. IDR Medical has been involved in a number of studies to advise clients on clinical trial design for medical devices and technology. Our approach is to interview therapy specific KOL’s involved in the design and [...]

September 7th, 2011|News|

Healthcare Pricing Strategy Continues to be a Core Focus for IDR Medical

The key to success for our healthcare pricing strategy projects is designing a methodology which realistically predicts the market response at a range of price points. The challenge in a healthcare setting is to incorporate all of the decision makers: The clinical decision makers, the commercial and budgetary influencers and where appropriate the patient. We [...]

September 7th, 2011|News|

IDR Medical Develops Economic Cost-Benefit Models For New Medical Devices

In recent months IDR Medical have been involved in a number of projects to understand price sensitivities in the context of the economic cost/benefit a particular device or technology can present to a customer. Examples of project outputs in the form of Cost-Benefit Models are: Revenue models; to understand the impact of differing levels of [...]

September 7th, 2011|News|

Developing Market Expertise in Regenerative Medicine

Regenerative medicine is an emerging interdisciplinary field of research and clinical applications focused on the repair, replacement or regeneration of cells, tissues, bones or organs. It uses a combination of approaches including soluble molecules, gene therapy, stem cell transplantation, tissue engineering, and the reprogramming of cell and tissue types. IDR Medical has been working with [...]

September 7th, 2011|News|